Interpretation of Incidence Rates Data
Incidence Rate Report by State
Lung & Bronchus (Late Stage^), 2017-2021
All Races (includes Hispanic), Both Sexes, All Ages
Sorted by Ruralurban
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 34.3 with a 95% confidence interval from 34.2 to 34.4 and 140,561 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 64.9
District of Columbia6
- Rate : The incidence rate is 26.7 with a 95% confidence interval from 25.0 to 28.6 and 179 average annual cases over 2017-2021.
- CI*Rank ⋔ : 43 (41, 47)
- Percent of Cases with Late Stage : 59.9
Puerto Rico6
- Rate : The incidence rate is 7.5 with a 95% confidence interval from 7.2 to 7.9 and 342 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 49.2
Alabama6
- Rate : The incidence rate is 35.2 with a 95% confidence interval from 34.6 to 35.9 and 2,359 average annual cases over 2017-2021.
- CI*Rank ⋔ : 24 (21, 29)
- Percent of Cases with Late Stage : 60.6
Alaska6
- Rate : The incidence rate is 34.4 with a 95% confidence interval from 32.4 to 36.5 and 253 average annual cases over 2017-2021.
- CI*Rank ⋔ : 29 (18, 36)
- Percent of Cases with Late Stage : 66.2
Arizona6
- Rate : The incidence rate is 25.4 with a 95% confidence interval from 24.9 to 25.9 and 2,412 average annual cases over 2017-2021.
- CI*Rank ⋔ : 45 (43, 46)
- Percent of Cases with Late Stage : 60.1
Arkansas6
- Rate : The incidence rate is 42.7 with a 95% confidence interval from 41.7 to 43.6 and 1,690 average annual cases over 2017-2021.
- CI*Rank ⋔ : 8 (5, 11)
- Percent of Cases with Late Stage : 62.6
California3
- Rate : The incidence rate is 24.5 with a 95% confidence interval from 24.3 to 24.7 and 11,010 average annual cases over 2017-2021.
- CI*Rank ⋔ : 47 (46, 47)
- Percent of Cases with Late Stage : 67.1
Colorado6
- Rate : The incidence rate is 23.3 with a 95% confidence interval from 22.7 to 23.8 and 1,505 average annual cases over 2017-2021.
- CI*Rank ⋔ : 48 (47, 48)
- Percent of Cases with Late Stage : 62.5
Connecticut3
- Rate : The incidence rate is 34.7 with a 95% confidence interval from 34.0 to 35.5 and 1,687 average annual cases over 2017-2021.
- CI*Rank ⋔ : 26 (22, 30)
- Percent of Cases with Late Stage : 63.0
Delaware6
- Rate : The incidence rate is 35.9 with a 95% confidence interval from 34.4 to 37.3 and 512 average annual cases over 2017-2021.
- CI*Rank ⋔ : 22 (17, 30)
- Percent of Cases with Late Stage : 64.2
Florida6
- Rate : The incidence rate is 34.6 with a 95% confidence interval from 34.3 to 34.9 and 11,291 average annual cases over 2017-2021.
- CI*Rank ⋔ : 27 (23, 30)
- Percent of Cases with Late Stage : 63.3
Georgia3
- Rate : The incidence rate is 38.9 with a 95% confidence interval from 38.4 to 39.4 and 4,758 average annual cases over 2017-2021.
- CI*Rank ⋔ : 14 (13, 16)
- Percent of Cases with Late Stage : 69.2
Hawaii3
- Rate : The incidence rate is 28.5 with a 95% confidence interval from 27.4 to 29.6 and 578 average annual cases over 2017-2021.
- CI*Rank ⋔ : 42 (39, 43)
- Percent of Cases with Late Stage : 71.5
Idaho3
- Rate : The incidence rate is 30.6 with a 95% confidence interval from 29.5 to 31.6 and 675 average annual cases over 2017-2021.
- CI*Rank ⋔ : 38 (34, 41)
- Percent of Cases with Late Stage : 68.1
Illinois3
- Rate : The incidence rate is 38.4 with a 95% confidence interval from 37.9 to 38.8 and 6,143 average annual cases over 2017-2021.
- CI*Rank ⋔ : 15 (14, 17)
- Percent of Cases with Late Stage : 66.1
Iowa3
- Rate : The incidence rate is 42.0 with a 95% confidence interval from 41.2 to 43.0 and 1,766 average annual cases over 2017-2021.
- CI*Rank ⋔ : 9 (7, 12)
- Percent of Cases with Late Stage : 69.2
Kansas6
- Rate : The incidence rate is 34.6 with a 95% confidence interval from 33.7 to 35.5 and 1,262 average annual cases over 2017-2021.
- CI*Rank ⋔ : 28 (22, 31)
- Percent of Cases with Late Stage : 66.5
Kentucky3
- Rate : The incidence rate is 57.7 with a 95% confidence interval from 56.9 to 58.6 and 3,392 average annual cases over 2017-2021.
- CI*Rank ⋔ : 1 (1, 1)
- Percent of Cases with Late Stage : 68.5
Louisiana3
- Rate : The incidence rate is 43.8 with a 95% confidence interval from 43.0 to 44.6 and 2,540 average annual cases over 2017-2021.
- CI*Rank ⋔ : 6 (4, 8)
- Percent of Cases with Late Stage : 72.1
Maine6
- Rate : The incidence rate is 44.4 with a 95% confidence interval from 43.1 to 45.7 and 947 average annual cases over 2017-2021.
- CI*Rank ⋔ : 4 (3, 8)
- Percent of Cases with Late Stage : 65.7
Maryland6
- Rate : The incidence rate is 31.8 with a 95% confidence interval from 31.2 to 32.4 and 2,455 average annual cases over 2017-2021.
- CI*Rank ⋔ : 36 (33, 38)
- Percent of Cases with Late Stage : 64.1
Michigan6
- Rate : The incidence rate is 39.5 with a 95% confidence interval from 39.0 to 40.0 and 5,396 average annual cases over 2017-2021.
- CI*Rank ⋔ : 13 (12, 15)
- Percent of Cases with Late Stage : 67.3
Minnesota6
- Rate : The incidence rate is 32.8 with a 95% confidence interval from 32.2 to 33.4 and 2,351 average annual cases over 2017-2021.
- CI*Rank ⋔ : 33 (30, 35)
- Percent of Cases with Late Stage : 60.6
Mississippi6
- Rate : The incidence rate is 46.6 with a 95% confidence interval from 45.6 to 47.6 and 1,759 average annual cases over 2017-2021.
- CI*Rank ⋔ : 3 (3, 4)
- Percent of Cases with Late Stage : 67.8
Missouri6
- Rate : The incidence rate is 43.9 with a 95% confidence interval from 43.2 to 44.5 and 3,570 average annual cases over 2017-2021.
- CI*Rank ⋔ : 5 (4, 8)
- Percent of Cases with Late Stage : 65.3
Montana6
- Rate : The incidence rate is 28.8 with a 95% confidence interval from 27.6 to 30.1 and 447 average annual cases over 2017-2021.
- CI*Rank ⋔ : 41 (38, 43)
- Percent of Cases with Late Stage : 62.8
Nebraska6
- Rate : The incidence rate is 32.4 with a 95% confidence interval from 31.3 to 33.4 and 777 average annual cases over 2017-2021.
- CI*Rank ⋔ : 34 (30, 38)
- Percent of Cases with Late Stage : 62.1
Nevada6
- Rate : The incidence rate is 26.0 with a 95% confidence interval from 25.2 to 26.7 and 984 average annual cases over 2017-2021.
- CI*Rank ⋔ : 44 (43, 46)
- Percent of Cases with Late Stage : 59.1
New Hampshire6
- Rate : The incidence rate is 38.1 with a 95% confidence interval from 36.8 to 39.4 and 756 average annual cases over 2017-2021.
- CI*Rank ⋔ : 16 (13, 22)
- Percent of Cases with Late Stage : 64.6
New Jersey3
- Rate : The incidence rate is 31.9 with a 95% confidence interval from 31.4 to 32.4 and 3,781 average annual cases over 2017-2021.
- CI*Rank ⋔ : 35 (33, 37)
- Percent of Cases with Late Stage : 65.1
New Mexico3
- Rate : The incidence rate is 19.5 with a 95% confidence interval from 18.8 to 20.3 and 554 average annual cases over 2017-2021.
- CI*Rank ⋔ : 49 (49, 49)
- Percent of Cases with Late Stage : 60.1
New York3
- Rate : The incidence rate is 33.5 with a 95% confidence interval from 33.2 to 33.8 and 8,734 average annual cases over 2017-2021.
- CI*Rank ⋔ : 31 (28, 33)
- Percent of Cases with Late Stage : 62.7
North Carolina6
- Rate : The incidence rate is 42.0 with a 95% confidence interval from 41.5 to 42.5 and 5,597 average annual cases over 2017-2021.
- CI*Rank ⋔ : 10 (8, 11)
- Percent of Cases with Late Stage : 67.3
North Dakota6
- Rate : The incidence rate is 36.7 with a 95% confidence interval from 34.9 to 38.5 and 336 average annual cases over 2017-2021.
- CI*Rank ⋔ : 20 (14, 29)
- Percent of Cases with Late Stage : 65.5
Ohio6
- Rate : The incidence rate is 41.9 with a 95% confidence interval from 41.5 to 42.4 and 6,615 average annual cases over 2017-2021.
- CI*Rank ⋔ : 11 (8, 11)
- Percent of Cases with Late Stage : 65.4
Oklahoma6
- Rate : The incidence rate is 40.5 with a 95% confidence interval from 39.7 to 41.3 and 1,976 average annual cases over 2017-2021.
- CI*Rank ⋔ : 12 (11, 13)
- Percent of Cases with Late Stage : 64.3
Oregon6
- Rate : The incidence rate is 29.6 with a 95% confidence interval from 28.9 to 30.2 and 1,681 average annual cases over 2017-2021.
- CI*Rank ⋔ : 39 (38, 42)
- Percent of Cases with Late Stage : 62.2
Pennsylvania6
- Rate : The incidence rate is 37.5 with a 95% confidence interval from 37.1 to 37.9 and 6,864 average annual cases over 2017-2021.
- CI*Rank ⋔ : 18 (16, 21)
- Percent of Cases with Late Stage : 64.8
Rhode Island6
- Rate : The incidence rate is 35.7 with a 95% confidence interval from 34.3 to 37.1 and 526 average annual cases over 2017-2021.
- CI*Rank ⋔ : 23 (17, 30)
- Percent of Cases with Late Stage : 59.3
South Carolina6
- Rate : The incidence rate is 37.6 with a 95% confidence interval from 37.0 to 38.3 and 2,630 average annual cases over 2017-2021.
- CI*Rank ⋔ : 17 (15, 21)
- Percent of Cases with Late Stage : 64.7
South Dakota6
- Rate : The incidence rate is 36.5 with a 95% confidence interval from 34.9 to 38.2 and 414 average annual cases over 2017-2021.
- CI*Rank ⋔ : 21 (14, 29)
- Percent of Cases with Late Stage : 66.8
Tennessee6
- Rate : The incidence rate is 43.5 with a 95% confidence interval from 42.9 to 44.2 and 3,882 average annual cases over 2017-2021.
- CI*Rank ⋔ : 7 (4, 8)
- Percent of Cases with Late Stage : 64.2
Texas3
- Rate : The incidence rate is 29.4 with a 95% confidence interval from 29.2 to 29.7 and 8,730 average annual cases over 2017-2021.
- CI*Rank ⋔ : 40 (38, 42)
- Percent of Cases with Late Stage : 64.6
Utah3
- Rate : The incidence rate is 17.0 with a 95% confidence interval from 16.4 to 17.7 and 492 average annual cases over 2017-2021.
- CI*Rank ⋔ : 50 (50, 50)
- Percent of Cases with Late Stage : 69.0
Vermont6
- Rate : The incidence rate is 34.7 with a 95% confidence interval from 33.0 to 36.5 and 332 average annual cases over 2017-2021.
- CI*Rank ⋔ : 25 (19, 34)
- Percent of Cases with Late Stage : 64.1
Virginia6
- Rate : The incidence rate is 33.1 with a 95% confidence interval from 32.6 to 33.6 and 3,535 average annual cases over 2017-2021.
- CI*Rank ⋔ : 32 (30, 34)
- Percent of Cases with Late Stage : 64.7
Washington5
- Rate : The incidence rate is 31.4 with a 95% confidence interval from 30.9 to 32.0 and 2,914 average annual cases over 2017-2021.
- CI*Rank ⋔ : 37 (34, 38)
- Percent of Cases with Late Stage : 64.6
West Virginia6
- Rate : The incidence rate is 52.0 with a 95% confidence interval from 50.8 to 53.3 and 1,405 average annual cases over 2017-2021.
- CI*Rank ⋔ : 2 (2, 2)
- Percent of Cases with Late Stage : 68.0
Wisconsin6
- Rate : The incidence rate is 36.9 with a 95% confidence interval from 36.3 to 37.5 and 2,920 average annual cases over 2017-2021.
- CI*Rank ⋔ : 19 (17, 23)
- Percent of Cases with Late Stage : 66.4
Wyoming6
- Rate : The incidence rate is 24.9 with a 95% confidence interval from 23.3 to 26.6 and 185 average annual cases over 2017-2021.
- CI*Rank ⋔ : 46 (43, 48)
- Percent of Cases with Late Stage : 63.4
- Rate : Data not available for this combination of data selections.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2024 3:40 pm.
State Cancer Registries may provide more current or more local data.
Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.